kymab.com Report : Visit Site

Technical data of the kymab.com

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host kymab.com. Currently, hosted in United Kingdom and its service provider is DigitalOcean London .

the related websites

malinplc.com 3newsquare.co.uk justice.gov.uk powellgilbert.com 14mg.co.uk bicycletherapeutics.com ft.com babraham.co.uk adf.org.au access.fda.gov bluelatitude.net strath.ac.uk 

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called nginx/1.4.6 (Ubuntu) containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

we use cookies on our website. carry on browsing if you’re happy with this or find out more home company back < company people our investors our vision our history pipeline back < pipeline inflammatory disease haematology infectious disease immuno-oncology technology back < technology antibody discovery bispecific antibodies vaccines innovative antibodies partnerships back < partnerships bill & melinda gates foundation md anderson cancer center heptares novo nordisk how our partnerships work careers back < careers working at our culture our location news & events back < news & events news events press office contact smarter science, better treatments based in cambridge, uk, we are making better medicines by continually improving the best antibody technologies learn more unique antibodies, unique solutions our unique technologies drive our rapid development of effective, human antibodies across our four main therapeutic areas - immuno-oncology, inflammation, haematology and infectious disease. view our pipeline world-leading partners view our partnerships come and make a difference with us join us in developing tomorrow's medicines: we're driven by passion for better healthcare and by compassion to make a difference. join our experienced and successful team and help us to realise our aims. view our vacancies our latest news and events 28 jun 2018 and roche clinical trial agreement for ky1044 first study to combine an anti-icos antibody with an anti-pd-l1 antibody in phase i/ii studies will evaluate 's lead investigational... read article 18 apr 2018 presents data on two of its immuno-oncology antibodies, providing further evidence of the strength of its franchise presented data on ky1044, a novel anti-icos antibody, and ky1055, a novel icos/pd-l1 bispecific antibody, at the american associati... read article 28 mar 2018 statement on uk court of appeal’s decision statement on the uk court of appeal’s decision regarding the validity of regeneron’s uk velocimmune patents read article conferences european society for medical oncology 2018 congress 19 oct 2018 - 23 oct 2018 | messe munich, munich, germany view event details conferences society for immunotherapy of cancer 33rd annual meeting 7 nov 2018 - 11 nov 2018 | walter e. washington convention center, washington, usa view event details conferences 60th annual meeting & exposition of the american society of hematology 1 dec 2018 - 4 dec 2018 | san diego convention center, san diego, california, usa view event details view all news view all events quick links home company pipeline technology partnerships careers news & events contact about since our founding in 2010, has raised $220 million in equity financing from leading investors to enable it to develop the kymouse™ platform and create a portfolio of therapeutic antibody assets. contact telephone +44 (0)1223 833301 general enquiries [email protected] media enquiries [email protected] partnering enquiries [email protected] linkedin twitter © 2018 terms and conditions privacy and cookies copyright designed & developed by onespacemedia

URL analysis for kymab.com

http://www.kymab.com/pipeline/immuno-oncology/
http://www.kymab.com/technology/innovative-antibodies/
http://www.kymab.com/technology/vaccines/
http://www.kymab.com/news-and-events/news/2018/mar/28/kymab-statement-uk-court-appeals-decision/
http://www.kymab.com/pipeline/inflammatory-disease/
http://www.kymab.com/news-and-events/press-office/
http://www.kymab.com/company/
http://www.kymab.com/privacy-and-cookie-policy
http://www.kymab.com/careers/working-kymab/
http://www.kymab.com/news-and-events/news/
http://www.kymab.com/news-and-events/events/society-immunotherapy-cancer-33rd-annual-meeting/
http://www.kymab.com/company/our-history/
http://www.kymab.com/pipeline/infectious-disease/
http://www.kymab.com/company/our-investors/
http://www.kymab.com/pipeline/

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Domain Name: KYMAB.COM
Registry Domain ID: 1568823750_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.123-reg.co.uk
Registrar URL: http://www.meshdigital.com
Updated Date: 2016-08-05T15:44:21Z
Creation Date: 2009-09-12T14:54:37Z
Registry Expiry Date: 2019-09-12T14:54:37Z
Registrar: 123-Reg Limited
Registrar IANA ID: 1515
Registrar Abuse Contact Email:
Registrar Abuse Contact Phone:
Domain Status: ok https://icann.org/epp#ok
Name Server: NS.123-REG.CO.UK
Name Server: NS2.123-REG.CO.UK
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2017-08-27T12:37:10Z <<<

For more information on Whois status codes, please visit https://icann.org/epp

NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.

TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.

The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.

  REGISTRAR 123-Reg Limited

SERVERS

  SERVER com.whois-servers.net

  ARGS domain =kymab.com

  PORT 43

  TYPE domain

DOMAIN

  NAME kymab.com

  CHANGED 2016-08-05

  CREATED 2009-09-12

STATUS
ok https://icann.org/epp#ok

NSERVER

  NS.123-REG.CO.UK 212.67.202.2

  NS2.123-REG.CO.UK 62.138.132.21

  REGISTERED yes

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .